Skip to content

Feasibility and effects of galantamine on cognition in humans with cannabis use disorder.

Randomized controlled trial · Pharmacol Biochem Behav · 2019. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 31082417

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Feasibility and effects of galantamine on cognition in humans with cannabis use disorder.

Sugarman DE, De Aquino JP, Poling J et al.
Pharmacol Biochem Behav · 2019

PubMed ID
31082417
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.